The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...

CAR T-cell therapies achieve high response rates in relapsed/refractory MCL but have severe toxicities and complex manufacturing processes. Bispecific antibodies offer logistical advantages and ...

Cell-surface RNAs, including glycoRNAs, have been described, yet their precise composition across primary cell types remains unresolved, in part due to technical challenges in preserving membrane ...

Cells bumping against one another use electricity to identify which of their neighbors has the least energy to expel them. The King's College London study in partnership with the Francis Crick ...

Chimeric antigen receptor (CAR) T-cell therapy and bispecific antibodies are transforming multiple myeloma care, with earlier use, expanded community access, and outpatient delivery models offering ...

Glial cells, also known as neuroglia, are non-neuronal cells that play a crucial role in various neurophysiological processes. They not only support nervous system structures but also contribute to ...

Scientists say they captured 3D images of a new organelle they're calling a "hemifusome," which may be a recycling center in human cells. When you purchase through links on our site, we may earn an ...

Amivantamab is a bispecific antibody targeting epidermal growth factor receptor (EGFR) and mesenchymal-epithelial transition factor, demonstrating efficacy in patients with non–small cell lung cancer ...